Pharmaceutical

ConcertAI and Bayer to boost precision oncology with AI...

ConcertAI has announced an agreement with Bayer that allows the latter to utilis...

TNF and Renova Health use AI to identify patients for G...

TNF and Renova Health are set to use AI and ML for the identification of high-ri...

First two medicinal products to undergo EU joint clinic...

In April 2025, the EU announced details about the first two medicinal products t...

Biogen’s Friedreich’s ataxia treatment authorised in UK

Biogen Netherlands has received marketing authorisation from the UK MHRA for its...

Eli Lilly sues Mochi Health and others for ‘deceptive’ ...

The lawsuit filings are the latest turn in a long-running legal saga between GLP...

Roche announces $50bn US investment in pharma and diagn...

Roche is set to invest $50bn in pharmaceuticals and diagnostics in the US over t...

FDA grants breakthrough status to uniQure’s Huntington’...

The US Food and Drug Administration (FDA) has awarded breakthrough therapy desig...

UK’s MHRA authorises GSK’s Blenrep for multiple myeloma...

The UK's Medicines and Healthcare products Regulatory Agency (MHRA) has authoris...

Sanofi and Regeneron’s dupilumab approved by FDA for ur...

Sanofi and Regeneron's Dupixent (dupilumab) has gained approval from the FDA for...

ACIP recommends GSK’s RSV vaccine for at-risk adults 50...

The ACIP has voted to recommend the use of respiratory syncytial virus (RSV) vac...

Trump order eases Medicare price negotiation for small ...

The executive order aims to lower prescription prices, but targets the mechanism...

Glycomine raises $115m to advance rare disease therapy ...

Glycomine’s Series C raise highlights investor confidence in the company amid pr...

WHO member states agree on treaty to fight future pande...

The agreement is seen as a win for global health ahead of the US withdrawal from...

Podcast: What’s next for the pharma tariffs?

Our editorial team dissects the latest developments in the ongoing story of how ...

Eli Lilly’s shares up as oral GLP-1RA scores in first P...

Lilly plans to submit orforglipron for approval in weight management by the end ...